New radiation approach aims to stop pancreatic cancer return after surgery

NCT ID NCT05043857

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a precise, high-dose radiation technique called SBRT can lower the chance of cancer coming back in the pancreas area after surgery. The study involves 50 adults with pancreatic cancer who had surgery and are at high risk of recurrence. They will receive SBRT in 5 sessions, targeting the surgical bed and nearby areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Stereotactic Body Radiotherapy (SBRT)

What this could lead to

If successful, this could offer a more effective and shorter radiation option after surgery to help prevent the cancer from coming back in the pancreas area.

What could go wrong

This is a small, early-phase trial (50 people) without a comparison group, so results may not be definitive. Radiation can also cause side effects to nearby organs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Humanitas Research Hospital

    Rozzano, MI, 20089, Italy